본문 바로가기

Promising Therapeutic Strategies for Mesenchymal Stem Cell-Based Cardiovascular Regeneration: From Cell Priming to Tissue Engineering

문서 유형
연구출판물 · 리뷰논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q3
저널
STEM CELLS INTERNATIONAL2017 · 2017
피인용
Web of Science 70Scopus 72
FWCI (Scopus)
2.11
JCR IF
JCR 2016 3.54
ISSN
1687-966X

저자

  1. 지승택제1저자Laboratory for Vascular Medicine and Stem Cell Biology, Convergence Stem Cell Research Center, Medical Research Institute, Pusan National University, School of Medicine, Yangsan, South Korea
  2. 김현윤Laboratory for Vascular Medicine and Stem Cell Biology, Convergence Stem Cell Research Center, Medical Research Institute, Pusan National University, School of Medicine, Yangsan, South Korea
  3. 윤지수Laboratory for Vascular Medicine and Stem Cell Biology, Convergence Stem Cell Research Center, Medical Research Institute, Pusan National University, School of Medicine, Yangsan, South Korea
  4. 정주섭Department of Internal Medicine, Medical Research Institute, Pusan National University, School of Medicine, Busan, South Korea
  5. 권상모교신저자Laboratory for Vascular Medicine and Stem Cell Biology, Convergence Stem Cell Research Center, Medical Research Institute, Pusan National University, School of Medicine, Yangsan, South Korea

초록

The primary cause of death among chronic diseases worldwide is ischemic cardiovascular diseases, such as stroke and myocardial infarction. Recent evidence indicates that adult stem cell therapies involving cardiovascular regeneration represent promising strategies to treat cardiovascular diseases. Owing to their immunomodulatory properties and vascular repair capabilities, mesenchymal stem cells (MSCs) are strong candidate therapeutic stem cells for use in cardiovascular regeneration. However, major limitations must be overcome, including their very low survival rate in ischemic lesion. Various attempts have been made to improve the poor survival and longevity of engrafted MSCs. In order to develop novel therapeutic strategies, it is necessary to first identify stem cell modulators for intracellular signal triggering or niche activation. One promising therapeutic strategy is the priming of therapeutic MSCs with stem cell modulators before transplantation. Another is a tissue engineering-based therapeutic strategy involving a cell scaffold, a cell-protein-scaffold architecture made of biomaterials such as ECM or hydrogel, and cell patch-and 3D printing-based tissue engineering. This review focuses on the current clinical applications of MSCs for treating cardiovascular diseases and highlights several therapeutic strategies for promoting the therapeutic efficacy of MSCs in vitro or in vivo from cell priming to tissue engineering strategies, for use in cardiovascular regeneration.

키워드

HUMAN ADIPOSE-TISSUEACUTE MYOCARDIAL-INFARCTIONHUMAN BONE-MARROWHUMAN ARTICULAR-CARTILAGEEPIDERMAL-GROWTH-FACTORSTROMAL CELLSISCHEMIC CARDIOMYOPATHYPROGENITOR CELLSIN-VITROCHONDROGENIC DIFFERENTIATION

식별자

Scopus EID
2-s2.0-85020177951
WoS UID
000396140900001